Previously Funded Researchers

John Schoggins, Ph.D.

UT Southwestern Medical Center

New Avenue for Keeping Influenza in Check

Andreas Schwingshackl, MD, PhD

University of California, Los Angeles

TREK-1 potassium channels protect from ventilator-induced lung injury

Jessica Seeliger, Ph.D.

State University of New York, Stony Brook

Targeting Latent and Multi-Drug Resistant TB

Leopoldo Nicolas Segal, MD

New York University School of Medicine

Recognizing Treatable Traits Among Critically Ill COVID-19 Patients

Shiladitya Sengupta, Ph.D.

Brigham and Women's Hospital, Inc.

Using Nanotechnology to Target Lung Cancer

Lecia V. Sequist, M.D., MPH

Associate Professor, Medicine, Harvard Medical School and Attending Physician, Medicine

Massachusetts General Hospital

Lung Cancer Interception Translational Research Team: Blood-based Early Interception of Lung Cancer

Brittany Sexton, Ph.D.

Massachusetts General Hospital

Discovering Inner Workings of Enzyme Could Lead to Lung Cancer Treatment

David Brian Shackelford, PhD

University of California, Los Angeles

Testing Novel Compound to Treat KRAS/LKB1 Mutant Lung Tumors

David Shackelford, Ph.D.

University of California, Los Angeles

Selectively Targeting Metabolic Needs Unique to Lung Cancer

Lokesh Sharma, PhD

Yale University

Mechanisms of Paradoxical Anti-inflammatory Effects of Type I Interferons in the Lung

Mohammed Shatat, M.D.

Case Western Reserve University

Molecule Could Play Role in Improving Treatment of PAH

David Shechter, Ph.D.

Albert Einstein College of Medicine, Inc.

When the Writing Goes Wrong: Protein Arginine Methyltransferases in Lung Cancer

Abdul Sheikh, Ph.D.

Yale University

Abnormal Lung Blood Vessel Muscle Formation and Pulmonary Hypertension

Jinjun Shi, Ph.D.

Brigham and Women's Hospital, Inc.

Making Lung Cancer Responsive to Treatment for Other Cancers

Megumi Shigematsu, PhD

Thomas Jefferson University

Hidden Short RNAs as Novel Inflammatory Mediators in Asthma

Sunny Shin, Ph.D.

University of Pennsylvania

How Immune Cells Clear Legionnaire's Disease Bacteria from Lungs

Hideki Shishido, Ph.D.

Oregon Health and Science University

Developing New Method to Study Cystic Fibrosis Protein

Binoy Shivanna, M.D., D.M.

Baylor College of Medicine

Preventing Lung Damage from Oxygen Used to Treat ARDS

Sheng Si, MD

Boston University

Determining Role of Genetic Mutation in Idiopathic Pulmonary Fibrosis

Anurag Singh, Ph.D.

Boston University

Understanding Role of Mutated KRAS Gene in Lung Cancer

Shannon Sirk, PhD

University of Illinois

Engineering Bacteria to Produce Targeted Biological Therapeutics

Kellie Smith, PhD

Johns Hopkins University

Anti-Tumor Immune Responses in Early-Stage Non-Small Cell Lung Cancer

Judith Smith, M.D., Ph.D.

University of Wisconsin-Madison

Understanding How a Gene Regulates Viral Asthma Triggers

Eric Snyder, MD, PhD

University of Utah

When Lung Tumors Change "Identity," How Does It Affect Treatment?

Adam C. Soloff, Ph.D.

University of Pittsburgh

Enhancing the Functionality of T cells for Next Generation Adoptive Cell Transfer Therapy for Advanced Lung Cancer

Samir Soneji, Ph.D.

Trustees of Dartmouth College

Does the Effectiveness of CT Screening Translate into Real-World Benefits?

Courtney Sparacino-Watkins, Ph.D.

University of Pittsburgh

Enzyme May Play Key Role in Pulmonary Arterial Hypertension

Srinivas Sridhar, Ph.D.

Northeastern University

Injectable Lung Cancer Therapy with PARP Inhibitors Could Better Target Tumor Cells

Shivani Srivastava, PhD

Fred Hutchinson Cancer Research Center

Enhancing Effectiveness of CAR-T Cell Therapy for Lung Cancer

Anup Srivastava, Ph.D.

University of Arizona Health Sciences

Studying Inflammation in Cigarette Smoke-Induced COPD